相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research
Steeve Provencher et al.
CIRCULATION RESEARCH (2018)
Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in chronic fibrosing interstitial pneumonia
Tsugumi Horikiri et al.
RESPIRATORY MEDICINE (2017)
Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension
Sebastien Bonnet et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
The molecular targets of approved treatments for pulmonary arterial hypertension
Marc Humbert et al.
THORAX (2016)
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Olivier Sitbon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The mechanistic basis of prostacyclin and its stable analogues in pulmonary arterial hypertension: Role of membrane versus nuclear receptors
Lucie H. Clapp et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
Assessing the agonist profiles of the prostacyclin analogues treprostinil and naxaprostene, particularly their DP1 activity
Nawazish-i-Husain Syed et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2015)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
The Interaction of Endothelin-1 and TGF-β1 Mediates Vascular Cell Remodeling
Christopher Lambers et al.
PLOS ONE (2013)
Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins
N. N. Orie et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor
Chabha Benyahia et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: Treprostinil is a potent DP1 and EP2 agonist
Brendan J. Whittle et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Inhibition of vascular adenosine triphosphate-sensitive potassium channels by sympathetic tone during sepsis
Yi-Ling Chan et al.
CRITICAL CARE MEDICINE (2012)
Differential Effects of Selexipag and Prostacyclin Analogs in Rat Pulmonary Artery
Keith Morrison et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Prostacyclins in Pulmonary Arterial Hypertension: the Need for Earlier Therapy
Jean-Luc Vachiery
ADVANCES IN THERAPY (2011)
Targeted Disruption of the Prostaglandin E2 E-Prostanoid 2 Receptor Exacerbates Vascular Neointimal Formation in Mice
Sen Zhu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
In vitro and in vivo characterization of PF-044189948, a novel, potent and selective prostaglandin EP2 receptor antagonist
K. J. af Forselles et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension
Dongmin Shao et al.
PHARMACOLOGICAL RESEARCH (2011)
Smooth Muscle Proliferation and Role of the Prostacyclin (IP) Receptor in Idiopathic Pulmonary Arterial Hypertension
Emilia Falcetti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Smad-Dependent and Smad-Independent Induction of Id1 by Prostacyclin Analogues Inhibits Proliferation of Pulmonary Artery Smooth Muscle Cells In Vitro and In Vivo
Jun Yang et al.
CIRCULATION RESEARCH (2010)
PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis
Maozhen Tian et al.
FASEB JOURNAL (2010)
Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
Paul M. Hassoun et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension
Ying-Ju Lai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Vasorelaxation induced by prostaglandin E2 in human pulmonary vein:: role of the EP4 receptor subtype
N. Foudi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Prostacyclin therapies for the treatment of pulmonary arterial hypertension
M. Gomberg-Maitland et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion
C. Shane McSwain et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug
Keiichi Kuwano et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities
David M. Aronoff et al.
JOURNAL OF IMMUNOLOGY (2007)
Pathology of pulmonary hypertension
Rubin M. Tuder et al.
CLINICS IN CHEST MEDICINE (2007)
Role of the adventitia in pulmonary vascular remodeling
KR Stenmark et al.
PHYSIOLOGY (2006)
Prostaglandin E2 inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity
ES White et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Increased sensitivity of asthmatic airway smooth muscle cells to prostaglandin E2 might be mediated by increased numbers of E-prostanoid receptors
JK Burgess et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Prostaglandin E-2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation
JE Kolodsick et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery
LH Clapp et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: Role of the carboxyl terminus in EP4 receptor sequestration
S Desai et al.
MOLECULAR PHARMACOLOGY (2000)
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs
M Abramovitz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
分享论文
